New Way Found to Boost Immunity in Fighting Cancer and Infections
An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve-Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and cancer. T-cells orchestrate the response of the immune system. This work outlines how a receptor termed LFA-1 on the surface of T-cells mediates adhesion to other cells such as cancer cells.
The work, published in Nature Communications, shows that LFA-1 mediates adhesion or de-adhesion by engaging a novel intracellular pathway in T-cells. International work over the past decade has underscored the importance of the manipulation of the immune system to combat cancers and infections. Manipulation of the new pathway outlined by Rudd and his co-researchers represents a new targeting strategy to promote immune-cell rejection of cancer.
"With this work," said Rudd, "we have found a new way to alter the overall immune response. We now have new tools to increase immune response against cancer and infections. The discovery could prove to be a major asset in the fight against several pathologies via the targeting of a single immune cell component."
"It is clear that Dr. Rudd's discovery represents a breakthrough in our ability to understand the immune system and to use it in the fight against cancer and infections," added Denis-Claude Roy, director of research at Maisonneuve-Rosemont Hospital. "This new mechanism allows us to identify the weaknesses of our present immunological approaches and to develop new weapons that are even more effective.
This article has been republished from materials provided by Université de Montréal. Note: material may have been edited for length and content. For further information, please contact the cited source.
Monika Raab, Yuning Lu, Karsten Kohler, Xin Smith, Klaus Strebhardt & Christopher E. Rudd, “LFA-1 activates focal adhesion kinases FAK1 / PYK2 to generate LAT-GRB2-SKAP1 complexes that terminate T-cell conjugate formation”, Nature Communications, 2017 July 12.DOI: 10.1038 / ncomms16001
Consuming Low-Calorie Sweeteners May Predispose Overweight Individuals to DiabetesNews
Consumption of low-calorie sweeteners could promote metabolic syndrome and predispose people to prediabetes and diabetes, particularly in individuals with obesity, a new study on human fat-derived stem cells and fat samples suggests.READ MORE
Unraveling How Mesenchymal Stem Cells From Gum Tissue Accelerate Wound HealingNews
To assist with wound healing, mesenchymal stem cells from the gum tissue secrete extracellular vesicles that contain the anti-inflammatory signaling molecule IL-1RA.READ MORE
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018